PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
Using a positron emission tomography (PET) tracer, researchers in the Netherlands have been able to identify differences in ER expression, which could help guide treatment for metastatic breast cancer patients. The study is featured in The Journal of Nuclear Medicine’s August issue. {read more here}
Giving patients knowledge of what to expect from an upcoming FDG-PET/CT scan can go a long way toward helping them to relax and improving their experience, according to a study published online August 3 in the Journal of Nuclear Medicine Technology. {read more here}
Hypoxia may have more of an impact in SBRT due to the fewer number of treatment fractions, which reduces the opportunity for re-oxygenation of hypoxic tumour cells. To investigate this premise, researchers from Yale University of School of Medicine have used 18F-FMISO PET to quantify changes in tumour hypoxia in response to SBRT Int. J. Radiat. Oncol. Bio. Phys. 102 174. {read more here}
When radiologists use strong, specific follow-up recommendations in FDG-PET/CT reports, referring physicians are more likely to follow their advice — and find cancers, according to a Dutch study published online July 29 in the Journal of the American College of Radiology. {read more here}